论文部分内容阅读
Ｅｉｓａｉ公司在美国申请上市新药Ａｒｉｃｅｐｔ日本Ｅｉｓａｉ公司在美国的子公司ＥＡ已在美国提交了新药Ａｒｉｃｅｐｔ（盐酸ｄｏｎｅｐｅｚｉｌ，以前称Ｅ２０２０）的上市申请。该药是一种新型的乙酰胆碱酯酶抑制剂，用于治疗早老性痴呆症。若该申请获得批准，Ａｒ...
Eisai to Apply for New Drug in the United States Aricept Japan’s Eisai subsidiary in the United States EA has submitted a listing application for the new drug, Aricept (formerly E2020), in the United States. This medicine is a novel acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. If the application is approved, Ar ...